Free Trial

Novo Nordisk A/S (NVO) Short Interest Ratio & Short Volume

Novo Nordisk A/S logo
$69.61 -0.55 (-0.79%)
As of 12:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Novo Nordisk A/S Short Interest Data

Novo Nordisk A/S (NVO) has a short interest of 12.64 million shares, representing 0.28% of the float (the number of shares available for trading by the public). This marks a -6.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 5.55 million shares to cover all short positions.

Current Short Interest
12,640,000 shares
Previous Short Interest
13,510,000 shares
Change Vs. Previous Month
-6.44%
Dollar Volume Sold Short
$976.09 million
Short Interest Ratio
1.4 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
4,487,532,000 shares
Short Percent of Float
0.28%
Today's Trading Volume
3,065,690 shares
Average Trading Volume
5,545,899 shares
Today's Volume Vs. Average
55%
Short Selling Novo Nordisk A/S?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Novo Nordisk A/S and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NVO Short Interest Over Time

NVO Days to Cover Over Time

NVO Percentage of Float Shorted Over Time

Remove Ads

Novo Nordisk A/S Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/202512,640,000 shares $976.09 million -6.4%0.3%1.4 $77.22
2/28/202513,510,000 shares $1.23 billion -0.2%0.3%1.5 $90.68
2/15/202513,530,000 shares $1.05 billion -0.3%0.3%1.6 $77.94
1/31/202513,570,000 shares $1.14 billion +64.1%N/A1.7 $84.36
1/15/20258,270,000 shares $686.33 million -0.4%N/A1.1 $82.99
12/31/20248,300,000 shares $713.97 million +76.6%N/A1.3 $86.02
12/15/20244,700,000 shares $502.67 million -17.3%N/A0.8 $106.95
11/30/20245,680,000 shares $606.62 million +15.2%N/A1.1 $106.80
11/15/20244,930,000 shares $501.58 million -18.5%N/A1 $101.74
10/31/20246,050,000 shares $677.36 million -4.9%N/A1.4 $111.96
10/15/20246,360,000 shares $749.40 million -9.5%N/A1.6 $117.83
9/30/20247,030,000 shares $836.92 million +21.2%N/A1.7 $119.05
9/15/20245,800,000 shares $794.60 million +13.1%N/A1.5 $137.00
8/31/20245,130,000 shares $713.89 million -2.7%N/A1.3 $139.16
8/15/20245,270,000 shares $724.99 million +30.1%N/A1.3 $137.57
7/31/20244,050,000 shares $537.15 million +28.6%N/A1 $132.63
7/15/20243,150,000 shares $445.38 million -30.3%N/A0.8 $141.39
6/30/20244,520,000 shares $645.18 million +3.7%N/A1.2 $142.74
6/15/20244,360,000 shares $621.30 million -2.7%N/A1.2 $142.50
5/31/20244,480,000 shares $606.14 million +20.8%N/A1.1 $135.30
5/15/20243,710,000 shares $499.51 million +1.9%N/A0.8 $134.64
4/30/20243,640,000 shares $466.94 million +12.4%N/A0.8 $128.28
4/15/20243,240,000 shares $401.27 million +14.5%N/A0.6 $123.85
3/31/20242,830,000 shares $363.37 million -31.1%N/A0.6 $128.40
3/15/20244,110,000 shares $543.96 million -15.8%N/A0.8 $132.35
2/29/20244,880,000 shares $584.33 million +4.5%N/A1 $119.74
2/15/20244,670,000 shares $568.43 million -37.9%N/A1 $121.72
1/31/20247,520,000 shares $862.47 million +37.7%N/A1.7 $114.69
1/15/20245,460,000 shares $585.09 million -5.0%N/A1.3 $107.16
12/31/20235,750,000 shares $594.84 million -11.1%N/A1.3 $103.45
12/15/20236,470,000 shares $628.04 million +15.5%N/A1.4 $97.07
11/30/20235,600,000 shares $570.33 million -6.2%N/A1.2 $101.85
11/15/20235,970,000 shares $575.63 million +34.8%N/A1.3 $96.42
10/31/20234,430,000 shares $427.81 million -26.3%N/A1 $96.57
10/15/20236,010,000 shares $613.86 million +1.7%N/A1.3 $102.14
9/30/20235,910,000 shares $537.46 million +5.4%N/A1.5 $90.94
9/15/20235,610,000 shares $267.03 million +187.7%0.3%1.6 $47.60
8/31/20231,950,000 shares $362.15 million -4.9%0.1%1.2 $185.72
8/15/20232,050,000 shares $379.50 million +106.0%0.1%1.4 $185.12
7/31/2023995,300 shares $160.34 million -21.0%0.1%0.7 $161.10
Elon Warns: Exec Order 14024 Targets Dollar (Ad)

Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.

Go Here to Learn What's Happening and How to Prepare >>
7/15/20231,260,000 shares $201.78 million -44.3%0.1%1 $160.14
6/30/20232,260,000 shares $365.74 million +9.2%0.1%1.6 $161.83
6/15/20232,070,000 shares $336.44 million +16.3%0.1%1.5 $162.53
5/31/20231,780,000 shares $285.69 million +14.1%0.1%1.3 $160.50
5/15/20231,560,000 shares $264.31 million +6.1%0.1%1.1 $169.43
4/30/20231,470,000 shares $245.62 million -14.5%0.1%1.1 $167.09
4/15/20231,720,000 shares $289.99 million -26.2%0.1%1.2 $168.60
3/31/20232,330,000 shares $370.80 million +66.4%0.1%1.7 $159.14
3/15/20231,400,000 shares $197.37 million +28.4%0.1%1 $140.98
2/28/20231,090,000 shares $153.68 million -3.5%0.1%0.8 $140.99
2/15/20231,130,000 shares $159.28 million -33.9%0.1%0.8 $140.96
1/31/20231,710,000 shares $237.31 million +3.6%0.1%1.2 $138.78
1/15/20231,650,000 shares $224.93 million -10.3%0.1%1.2 $136.32
12/30/20221,840,000 shares $249.03 million +34.3%0.1%1.4 $135.34
12/15/20221,370,000 shares $183.14 million -34.1%0.1%1 $133.68
11/30/20222,080,000 shares $259.17 million -20.6%0.1%1.6 $124.60
11/15/20222,620,000 shares $297.74 million -1.1%0.2%1.8 $113.64
10/31/20222,650,000 shares $288.43 million -17.7%0.2%1.7 $108.84
10/15/20223,220,000 shares $334.24 million +0.9%0.2%2 $103.80
9/30/20223,190,000 shares $317.82 million +2.2%0.2%1.9 $99.63
9/15/20223,120,000 shares $322.02 million -9.0%0.2%1.9 $103.21
8/31/20223,430,000 shares $363.92 million +48.5%0.2%2.1 $106.10
8/15/20222,310,000 shares $245.71 million +76.3%0.1%1.5 $106.37
7/31/20221,310,000 shares $152.04 million +26.0%0.1%0.9 $116.06
7/15/20221,040,000 shares $118.80 million -46.4%N/A0.7 $114.23
6/30/20221,940,000 shares $216.17 million -22.7%N/A1.3 $111.43
6/15/20222,510,000 shares $266.89 million +46.8%N/A1.7 $106.33
5/31/20221,710,000 shares $188.78 million -29.1%0.1%1.2 $110.40
5/15/20222,410,000 shares $255.56 million +39.3%0.1%1.6 $106.04
4/30/20221,730,000 shares $197.22 million -47.1%0.1%1.2 $114.00
4/15/20223,270,000 shares $386.51 million +58.0%0.2%2.3 $118.20
3/31/20222,070,000 shares $229.87 million -21.3%0.1%1.4 $111.05
3/15/20222,630,000 shares $269.44 million +10.0%0.2%1.7 $102.45
2/28/20222,390,000 shares $246.05 million -4.8%0.1%1.5 $102.95
2/15/20222,510,000 shares $254.41 million -24.6%0.1%1.7 $101.36
1/31/20223,330,000 shares $332.57 million +0.3%0.2%2.4 $99.87
1/15/20223,320,000 shares $319.78 million +18.2%0.2%2.6 $96.32
12/31/20212,810,000 shares $314.72 million +42.6%0.2%2.5 $112.00
12/15/20211,970,000 shares $229.43 million +3.1%0.1%1.9 $116.46
11/30/20211,910,000 shares $204.05 million -26.0%0.1%2.2 $106.83
11/15/20212,580,000 shares $292.80 million +22.3%0.2%2.8 $113.49
10/29/20212,110,000 shares $232.37 million -17.3%0.1%2.2 $110.13
10/15/20212,550,000 shares $260.97 million +8.1%0.2%2.5 $102.34
9/30/20212,360,000 shares $226.58 million -10.3%0.1%2.3 $96.01
9/15/20212,630,000 shares $266.34 million -24.0%0.2%2.6 $101.27
8/31/20213,460,000 shares $345.90 million +19.7%0.2%3.5 $99.97
8/13/20212,890,000 shares $296.98 million -30.5%0.2%3 $102.76
7/30/20214,160,000 shares $385.22 million -11.1%0.2%4.2 $92.60
7/15/20214,680,000 shares $410.01 million -5.1%0.3%5.2 $87.61
6/30/20214,930,000 shares $412.99 million -1.6%0.3%5.6 $83.77
Elon Warns: Exec Order 14024 Targets Dollar (Ad)

Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.

Go Here to Learn What's Happening and How to Prepare >>
6/15/20215,010,000 shares $423.70 million +7.1%0.3%5.6 $84.57
5/28/20214,680,000 shares $369.25 million +15.0%0.3%5.3 $78.90
5/14/20214,070,000 shares $321.08 million -15.2%0.2%4.6 $78.89
4/30/20214,800,000 shares $356.35 million +11.9%0.3%5 $74.24
4/15/20214,290,000 shares $302.66 million +1.4%0.2%4.4 $70.55
3/31/20214,230,000 shares $287.30 million -0.9%0.2%4.3 $67.92
3/15/20214,270,000 shares $303.21 million -6.2%0.2%4 $71.01
2/26/20214,550,000 shares $329.15 million +4.6%0.3%4.2 $72.34
2/12/20214,350,000 shares $321.60 million -12.7%0.2%4 $73.93
1/29/20214,980,000 shares $351.59 million +1.4%0.3%4.6 $70.60
1/15/20214,910,000 shares $348.76 million +21.2%0.3%4.3 $71.03
12/31/20204,050,000 shares $284.31 million -1.0%0.2%3.6 $70.20
12/15/20204,090,000 shares $281.06 million -17.9%0.2%3.6 $68.72
11/30/20204,980,000 shares $336.35 million -12.2%0.3%4.5 $67.54
11/15/20205,670,000 shares $386.01 million +13.2%0.3%5.3 $68.08
10/30/20205,010,000 shares $332.31 million +21.6%0.3%4.8 $66.33
10/15/20204,120,000 shares $295.53 million -1.2%0.2%4.4 $71.73
9/30/20204,170,000 shares $289.52 million -10.9%0.2%4.4 $69.43
9/15/20204,680,000 shares $317.87 million +19.1%0.3%4.9 $67.92
8/31/20203,930,000 shares $259.54 million +4.2%0.2%3.6 $66.04
8/14/20203,770,000 shares $247.95 million +35.1%0.2%3.3 $65.77
7/31/20202,790,000 shares $182.27 million -1.4%0.2%2.2 $65.33
7/15/20202,830,000 shares $185.34 million -17.5%0.2%2.2 $65.49
6/30/20203,430,000 shares $224.60 million No Change0.2%2.1 $65.48
6/15/20203,430,000 shares $221.61 million +25.2%0.2%1.8 $64.61
5/29/20202,740,000 shares $180.68 million +21.8%0.2%1.3 $65.94
5/15/20202,250,000 shares $144.65 million No Change0.1%1 $64.29
4/30/20202,250,000 shares $142.49 million -13.1%0.1%1 $63.33
4/15/20202,590,000 shares $155.01 million -22.2%0.1%1.1 $59.85
3/31/20203,330,000 shares $216.15 million -34.8%0.2%1.6 $64.91

NVO Short Interest - Frequently Asked Questions

What is Novo Nordisk A/S's current short interest?

Short interest is the volume of Novo Nordisk A/S shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 12,640,000 shares of NVO short. 0.28% of Novo Nordisk A/S's shares are currently sold short. Learn More on Novo Nordisk A/S's current short interest.

What is a good short interest ratio for Novo Nordisk A/S?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVO shares currently have a short interest ratio of 1.0. Learn More on Novo Nordisk A/S's short interest ratio.

Which institutional investors are shorting Novo Nordisk A/S?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Novo Nordisk A/S: Toronto Dominion Bank, GTS Securities LLC, Arrowpoint Investment Partners Singapore Pte. Ltd., Wolverine Trading LLC, Squarepoint Ops LLC, Tidal Investments LLC, Shay Capital LLC, Sig Brokerage LP, Point72 Asset Management L.P., Nomura Holdings Inc., OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC , Millennium Management LLC, LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Caption Management LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., 683 Capital Management LLC, Jane Street Group LLC, Optiver Holding B.V., Tudor Investment Corp ET AL, Artia Global Partners LP, CMT Capital Markets Trading GmbH, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, Hsbc Holdings PLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Kopernik Global Investors LLC, Capital Fund Management S.A., DRW Securities LLC, ADAR1 Capital Management LLC, National Bank of Canada FI, JPMorgan Chase & Co., Simplex Trading LLC, Twin Tree Management LP, Valeo Financial Advisors LLC, Genus Capital Management Inc., and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Novo Nordisk A/S?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.28% of Novo Nordisk A/S's floating shares are currently sold short.

Is Novo Nordisk A/S's short interest increasing or decreasing?

Novo Nordisk A/S saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 12,640,000 shares, a decline of 6.4% from the previous total of 13,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Novo Nordisk A/S's short interest compare to its competitors?

0.28% of Novo Nordisk A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Novo Nordisk A/S: AstraZeneca PLC (0.49%), Novartis AG (0.21%), Sanofi (0.23%), GSK plc (0.86%), Takeda Pharmaceutical Company Limited (0.14%), argenx SE (3.76%), BioNTech SE (1.36%), Teva Pharmaceutical Industries Limited (3.09%), Summit Therapeutics Inc. (24.59%), Intra-Cellular Therapies, Inc. (2.58%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Novo Nordisk A/S stock?

Short selling NVO is an investing strategy that aims to generate trading profit from Novo Nordisk A/S as its price is falling. NVO shares are trading down $1.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Novo Nordisk A/S?

A short squeeze for Novo Nordisk A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVO, which in turn drives the price of the stock up even further.

How often is Novo Nordisk A/S's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVO, twice per month. The most recent reporting period available is March, 15 2025.




This page (NYSE:NVO) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners